Ixazomib
Showing 1 - 25 of 142
Multiple Myeloma Trial in Hangzhou (Ixazomib plus low-dose lenalidomide, Ixazomib)
Recruiting
- Multiple Myeloma
- Ixazomib plus low-dose lenalidomide
- Ixazomib
-
Hangzhou, Zhejiang, ChinaYang Xu
Feb 9, 2023
Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)
Not yet recruiting
- Relapsed and Refractory Multiple Myeloma
- Mezigdomide
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 15, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Dexamethasone
- +2 more
-
Atlanta, Georgia
- +3 more
Jan 6, 2023
Kaposi Sarcoma, Skin Trial in Los Angeles, Saint Louis (Ixazomib Citrate, Quality-of-Life Assessment, Questionnaire
Suspended
- Kaposi Sarcoma
- Skin
- Ixazomib Citrate
- +2 more
-
San Diego, California
- +1 more
Jan 30, 2023
Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)
Active, not recruiting
- Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 10, 2023
Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Ixazomib
- +2 more
-
Duarte, California
- +9 more
Jan 11, 2023
Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,
Active, not recruiting
- Plasma Cell Myeloma
- Transplant-Related Carcinoma
- Ixazomib Citrate
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Jul 12, 2022
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Mantle-Cell Lymphoma Trial in United States (Ixazomib, Ibrutinib)
Active, not recruiting
- Mantle-Cell Lymphoma
- Ixazomib
- Ibrutinib
-
Atlanta, Georgia
- +13 more
Nov 17, 2022
Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)
Completed
- Human Immunodeficiency Virus (HIV)
- Ixazomib 1 MG
- +3 more
-
Rochester, MinnesotaMayo Clinic
Dec 8, 2021
Multiple Myeloma, High Risk Smoldering Multiple Myeloma Trial in United States (Ixazomib (MLN9708), Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- High Risk Smoldering Multiple Myeloma
- Ixazomib (MLN9708)
- Dexamethasone
-
Basking Ridge, New Jersey
- +5 more
Nov 15, 2022
Multiple Myeloma Trial in Pawtucket, Providence (Ixazomib, Cyclophosphamide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Ixazomib
- +2 more
-
Pawtucket, Rhode Island
- +2 more
Jul 21, 2022
Mantle Cell Lymphoma Trial in Busan (Ixazomib)
Recruiting
- Mantle Cell Lymphoma
- Ixazomib
-
Busan, Western, Korea, Republic ofKosin University Gospel Hospital
Mar 31, 2022
Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Multiple Myeloma in Relapse
- Ixazomib
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Apr 13, 2022
Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Smoldering Multiple Myeloma
- Ixazomib
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 15, 2022
AML, AML, Adult Trial in Indianapolis (TAK-659, Ixazomib)
Terminated
- AML
- AML, Adult
- TAK-659
- Ixazomib
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Cancer Center
Mar 15, 2022
Plasma Cell Myeloma Trial in Rochester (biological, drug, other)
Active, not recruiting
- Plasma Cell Myeloma
- Daratumumab
- +5 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2022
Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial
Recruiting
- Relapsing Remitting Multiple Sclerosis
- +2 more
- Ixazomib (NINLARO®) capsules / Matching placebo capsules
-
London, Greater London, United KingdomRoyal London Hospital, Barts Health NHS Foundation Trust
Feb 17, 2022
Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- Ixazomib
- +3 more
-
La Jolla, CaliforniaUCSD Moores Cancer Center
Mar 7, 2022
Plasmacytoma, POEMS Syndrome Trial in Rochester (Dexamethasone, Ixazomib Citrate, Lenalidomide)
Active, not recruiting
- Plasmacytoma
- POEMS Syndrome
- Dexamethasone
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
May 26, 2022
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Ixazomib
- +3 more
-
Badalona, Spain
- +7 more
May 20, 2022
Recurrent Plasma Cell Myeloma Trial in Rochester (drug, other, biological)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Dexamethasone
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
May 19, 2022
Systemic Sclerosis, Scleroderma, Diffuse Systemic Sclerosis Trial in Scottsdale (Ixazomib)
Recruiting
- Systemic Sclerosis
- +18 more
- Ixazomib
-
Scottsdale, ArizonaMayo Clinic in Arizona
May 3, 2022